NATURAL SITE PREFERENCE IN MAMMARY CANCER BIOLOGY
乳腺癌生物学中的自然位点偏好
基本信息
- 批准号:3168104
- 负责人:
- 金额:$ 20.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1980
- 资助国家:美国
- 起止时间:1980-06-01 至 1994-04-30
- 项目状态:已结题
- 来源:
- 关键词:adipose tissue breast neoplasms cellular oncology collagen contact inhibition embryo /fetus extracellular matrix growth factor growth media hormone related neoplasm /cancer intercellular connection laboratory mouse lactation mammary epithelium mammary gland mixed tissue /cell culture neoplasm /cancer immunology neoplasm /cancer pharmacology neoplasm /cancer transplantation neoplastic cell neoplastic growth neoplastic transformation preneoplastic state tissue /cell preparation
项目摘要
Mouse mammary tumors demonstrate a preference for growth in their
natural anatomic site, the mammary fatpad. Immunological
mechanisms do not adequately explain these site effects. We are
focusing on the role of intraepithelial and stromal-epithelial
cellular interactions. Our first specific aim is to determine the
role of soluble factors in the growth interactions. We have
developed an assay for diffusible growth factors in which both
producer and responder cells grow in a 3-dimensional array in
collagen gel matrix. The effect of normal mammary cells on tumor
cell and preneoplastic HAN cell growth in this assay accurately
reflects in vivo events; that is, both normal mammary epithelium
and normal mammary stroma stimulate growth of mammary tumor cells
but HAN cells are stimulated only by the stromal cells.
Preliminary evidence suggests a reciprocal paracrine interaction
in which tumor cells induce an element of normal mammary gland to
produce a factor mitogenic for tumor cells. This induction
involves a soluble factor produced by the tumor cells. A second
specific aim is to determine if normal mammary stroma and
epithelium also alter the growth of preneoplastic and neoplastic
cells via contact-dependent mechanisms. By utilizing mammary tumor
lines with drug resistance markers to study contact-dependent
metabolic cooperation between mammary tissues, we have found that
tumor cells are as able to communicate as normal mammary or
preneoplastic HAN cells, but that tumor cells may be less
responsive than normal or preneoplastic cells to regulators of gap
junctional communication. A third specific aim is to explore
further the possibility that tumor cells are refractory to
regulators (coupler and uncouplers) of contact-mediated
intercellular communication. Interactive homeostatic processes,
which occur between cells from the time of blastula formation, are
usually able to maintain tissue integrity throughout life and can
be regarded as mechanisms of "non-immune surveillance" against
neoplasia. Manipulation of tissue interactions could lead to new
therapeutic strategies against cancer growth and progression. Our
experimental approaches are based on the principles that cell
shape, tissue architecture, extracellular matrix, and stromal-
epithelial and intraepithelial interactions may all play
significant roles in neoplastic progression as well as in the
normal growth and development of the mammary gland.
小鼠乳腺肿瘤表现出对其生长的偏好
天然解剖部位,乳房脂肪垫。免疫学
机制不能充分解释这些场地效应。我们是
关注上皮内和间质上皮的作用
细胞间的相互作用。我们的第一个具体目标是确定
可溶性因子在生长互作中的作用。我们有
开发了一种可扩散生长因子的检测方法,其中既有
生产者和响应者细胞在3维阵列中生长
胶原蛋白凝胶基质。正常乳腺细胞对肿瘤的影响
本方法能准确测定汉族人细胞及癌前病变细胞生长
反映活体事件;也就是说,正常的乳腺上皮
正常乳腺间质刺激乳腺肿瘤细胞生长
但HAN细胞只受到基质细胞的刺激。
初步证据表明存在一种相互旁分泌作用
其中肿瘤细胞诱导正常乳腺的一种成分
为肿瘤细胞产生一种促分裂因子。这种归纳法
涉及一种由肿瘤细胞产生的可溶性因子。一秒钟
具体目的是确定正常的乳腺间质和
上皮细胞也改变癌前病变和肿瘤的生长
细胞通过接触依赖机制。利用乳腺肿瘤
携带耐药标记的品系研究接触依赖
乳腺组织之间的代谢合作,我们发现
肿瘤细胞的沟通能力与正常乳腺或
癌前韩氏细胞,但肿瘤细胞可能较少
比正常或癌前细胞对GAP调节因子的反应
交汇点通信。第三个具体目标是探索
此外,肿瘤细胞对
接触式调整器(耦合器和解偶器)
细胞间通信。互动的动态平衡过程,
从囊胚形成时起发生在细胞之间的
通常能够在一生中保持组织的完整性,并且可以
被视为“非免疫监视”机制
肿瘤。对组织相互作用的操纵可能带来新的
针对癌症生长和进展的治疗策略。我们的
实验方法基于这样的原理,即细胞
形状、组织结构、细胞外基质和基质-
上皮和上皮内的相互作用都可能起作用
在肿瘤进展中的重要作用以及在
乳腺的正常生长和发育。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRED Raymond MILLER其他文献
FRED Raymond MILLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRED Raymond MILLER', 18)}}的其他基金
Proteomics of Progression in MCF10 Xenograft Model
MCF10 异种移植模型进展的蛋白质组学
- 批准号:
6470342 - 财政年份:2002
- 资助金额:
$ 20.39万 - 项目类别:
Proteomics of Progression in MCF10 Xenograft Model
MCF10 异种移植模型进展的蛋白质组学
- 批准号:
6849197 - 财政年份:2002
- 资助金额:
$ 20.39万 - 项目类别:
Proteomics of Progression in MCF10 Xenograft Model
MCF10 异种移植模型进展的蛋白质组学
- 批准号:
6698074 - 财政年份:2002
- 资助金额:
$ 20.39万 - 项目类别:
MCF10DCIS.com as a preclinical chemopreventive screen
MCF10DCIS.com 作为临床前化学预防筛查
- 批准号:
6439397 - 财政年份:2002
- 资助金额:
$ 20.39万 - 项目类别:
MCF10DCIS.com as a preclinical chemopreventive screen
MCF10DCIS.com 作为临床前化学预防筛查
- 批准号:
6620013 - 财政年份:2002
- 资助金额:
$ 20.39万 - 项目类别:
Proteomics of Progression in MCF10 Xenograft Model
MCF10 异种移植模型进展的蛋白质组学
- 批准号:
6623819 - 财政年份:2002
- 资助金额:
$ 20.39万 - 项目类别:
LYMPHOKINE-TISSUE INTERACTIONS IN PRENEOPLASIA
肿瘤前期的淋巴因子与组织的相互作用
- 批准号:
2101948 - 财政年份:1993
- 资助金额:
$ 20.39万 - 项目类别:
LYMPHOKINE-TISSUE INTERACTIONS IN PRENEOPLASIA
肿瘤前期的淋巴因子与组织的相互作用
- 批准号:
2101949 - 财政年份:1993
- 资助金额:
$ 20.39万 - 项目类别:
LYMPHOKINE-TISSUE INTERACTIONS IN PRENEOPLASIA
肿瘤前期的淋巴因子与组织的相互作用
- 批准号:
2101950 - 财政年份:1993
- 资助金额:
$ 20.39万 - 项目类别:
LYMPHOKINE-TISSUE INTERACTIONS IN PRENEOPLASIA
肿瘤前期的淋巴因子与组织的相互作用
- 批准号:
3204700 - 财政年份:1993
- 资助金额:
$ 20.39万 - 项目类别:
相似海外基金
Pathology of Breast Neoplasms determined by MRS
MRS 测定乳腺肿瘤的病理学
- 批准号:
nhmrc : 950215 - 财政年份:1995
- 资助金额:
$ 20.39万 - 项目类别:
NHMRC Project Grants